Sofia Bragança

Dr. Sofia Bragança

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2024 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Open access
SBSofia Bragança
Sofia Bragança
AGAna Catarina Garcia
Ana Catarina Garcia
GAGonçalo Alexandrino
Gonçalo Alexandrino
AOAna Maria Oliveira
Ana Maria Oliveira
DHDavid Horta
David Horta
MCMariana Nuno Costa
Mariana Nuno Costa
Piecemeal endoscopic mucosal resection (pEMR) is the best approach to resect large lateral spreading tumors (LST, > 20 mm width). However, it is associated with early recurrence (ER) and late recurrence (LR). This study aims to assess the risk factors associated with ER and LR and to validate different predictive scores (SMSA, SERT, and BCM) in identifying the risk of ER and LR after LST resected by pEMR in a European cohort. Retrospective observational cohort study, based on a prospectively collected database, of large LST submitted to pEMR. A total of 108 patients were included in the study and the incidence rates of ER and LR were 22 % and 8 %, respectively. The lesion's size, SERT, and BCM scores were independent predictor factors of ER (p-value < 0.05), while the lesion's site and BCM score were independent predictor factors of LR (p-value < 0.05). For the prediction of ER, the SERT score (cut-off > 1) presented the highest AUROC (0.758 vs 0.697 from BCM and 0.647 from SMSA). Regarding LR, the BCM model (cut-off > 2) presented the highest AUROC (0.817 vs 0.708 from SERT and 0.691 from SMSA). We present the first external validation of the three scores mentioned in an European cohort. SERT and BCM scores had an acceptable performance in predicting ER and LR. However, the BCM model was the only score that proved to be an independent predictor of both ER and LR, proving to be valuable for both applications.

1 November 2022 in GE - Portuguese Journal of Gastroenterology
Verified
Journal Article
Open access
SBSofia Bragança
Sofia Bragança
MFMário Ferraz
Mário Ferraz
NGNuno Germano
Nuno Germano
Background: Acute liver failure (ALF) may represent an indication for liver transplantation (LT). However, in patients who do not meet the criteria or who have contraindications for LT, support measures remain indicated since they may improve survival. Continuous renal replacement therapy (CRRT) can be considered in the presence of hyperammonemia, 3 times above the upper normal limit, and hepatic encephalopathy (HE), even in the absence of the classic indications. High-volume plasma exchange (HVPE) is an artificial liver support system with proven benefits in ALF, allowing ammonia and inflammatory mediator clearance. Both techniques, HVPE and CRRT, are associated with an increase in transplant-free survival. Case Summary: We share a case of a 51-year-old male, without relevant personal history, diagnosed with severe acute hepatitis B which progressed to ALF, with grade IV HE (West-Haven criteria) and hyperammonemia (423 μg/dL). Due to the simultaneously diagnosed malignant neoplasm, he was not a candidate for LT. After refractory to medical therapy, HVPE was started, followed by CRRT. There was a significant improvement in liver tests, allowing surgical treatment of malignancy. After recovery, the patient returned to his everyday life. Conclusion: The authors present a successful case in which an early and invasive approach to ALF was revealed to be a game changer. The lack of response to the measures instituted, as well as the contraindication for LT, motivated the institution of HVPE and CRRT. Both techniques proved to be an asset, allowing complete clinical recovery, reaffirming their role in ALF.

29 September 2025 in GE - Portuguese Journal of Gastroenterology
Verified
Journal Article
Open access
SBSofia Bragança
Sofia Bragança
MFMónica Francisco
Mónica Francisco
HCHenrique Costa Coelho
Henrique Costa Coelho
MRMaria Ana Rafael
Maria Ana Rafael
LFLuísa Martins Figueiredo
Luísa Martins Figueiredo
AOAna Maria Oliveira
Ana Maria Oliveira
Aim: This study aimed to validate the Sodergren score (SS) in the Portuguese population and develop a new model incorporating symptoms and quality-of-life variables. Methods: A single-center, cross-sectional study conducted in patients diagnosed with grade I–III hemorrhoidal disease (HD) by gastroenterologists specialized in proctology between January and December 2023. The SS was translated and validated into Portuguese. Patients completed the Portuguese version of the SS and the EUROHIS-QOL-8. Demographic and clinical data were collected. The SS was validated using receiver operating characteristic curve analysis for identification of failure of office-based treatments (OBTs), defined as the need for ≥4 OBT. Additionally, based on SS variables, a new model (Amadora-Sintra) was developed, combining symptom and quality-of-life variables. Results: We included 87 patients (51.7% females) with a mean age of 59 years old (27–87). At the time of questionnaire collection, patients reported a median of 3 symptoms and prolapse was the most common (85.1%). On proctological examination, most of the patients presented HD Goligher grade II (75.9%). The median SS and EUROHIS-QOL-8 score were 3.0 and 3.5, respectively. The SS identified patients needing ≥4 OBT with an AUC = 0.719 (95% CI: [0.61–0.83]) at a cutoff of ≥3 (sensitivity 0.85, specificity 0.47). The Amadora-Sintra model showed superior performance with an AUC = 0.778 (95% CI: [0.66–0.90]), cutoff ≥0.105 (sensitivity 0.85, specificity 0.55). Conclusions: Both the SS and Amadora-Sintra models performed well in identifying patients who did not respond to OBT and consequently needed surgery, with the new model standing out for higher performance.

9 January 2023 in GE - Portuguese Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
SBSofia Bragança
Sofia Bragança
APAndré Pereira
André Pereira
GAGonçalo Alexandrino
Gonçalo Alexandrino
FMFilipa Moita
Filipa Moita
MCMariana Nuno Costa
Mariana Nuno Costa
DHDavid Horta
David Horta
We present the case of a 79-year-old male with known history of sigmoid colon cancer, diagnosed in the context of bowel obstruction in 2018. In that setting, he was submitted to an emergent Hartmann procedure, maintaining the colostomy ever since. After staging (IIIB AJCC classification), the patient completed 6 months of adjuvant chemotherapy (CT). The first and last colonoscopy was 6 months after surgery. No relapse was noticed during the surveillance period. Three years later, he developed oropharyngeal dysphagia, without any other gastrointestinal symptoms. Physical examination showed an asymmetric tonsillar hypertrophy and multiple soft and painless cervical adenomegalies. He was referred to otorhinolaryngology and hematology at a cancer center. The tonsil biopsy showed a classic mantle cell lymphoma (MCL), and the chromosomal translocation t(11; 14) was identified by fluorescence in situ hybridization technique. The staging computerized tomography scan revealed adenopathies above and below the diaphragm, a large cecal mass (shown in Fig. 1c), and a heterogeneous appearance of the colic and ileal mucosa (shown in Fig. 1a, b). A total colonoscopy was performed, and, between the colostomy and the terminal ileum, multiple polyps were identified (shown in Fig. 2a–c and Fig. 2e), some of them with central umbilication. In addition, a vegetating mass measuring 55 mm in diameter was observed in the cecum (shown in Fig. 2d). Biopsies of the polyps in the ileum, ascending and descending colon, as well as cecal mass were performed, and, in all of them, pathology showed a monomorphic lymphoid cell infiltrate (shown in Fig. 3a). The lymphoid cells stained positive for CD20 and CD5 and negative for CD3 (shown in Fig. 3b). In addition, cyclin-D1 nuclear overexpression was observed (shown in Fig. 3c). The patient was diagnosed with an MCL stage IVA (Ann-Arbor classification), with a high-risk MIPIb score. After completing 2 cycles of R-bendamustine (rituximab and bendamustine), he was diagnosed with COVID-19, and CT was suspended. The MCL remained stable while waiting for virologic cure. The patient restarted CT with R-CVP (rituximab, cyclophosphamide, vincristine, prednisolone), and a reevaluation colonoscopy will be performed at the end of 6th CT cycle.This case illustrates a silent presentation of an exuberant entity: multiple lymphomatous polyposis (MLP). MCL represents 6% of all non-Hodgkin lymphomas and is characterized by the chromosomal t(11; 14) which results in cyclin-D1 overexpression. The MCL affects mostly males in their 60–70 years and usually presents with disseminated disease, as seen in our patient [1]. Previously, gastrointestinal involvement was described in about 30% of the cases; however, it may be underestimated given the evidence of only microscopic involvement of the colon in about 84% of patients [2]. MLP is the most frequent colonic endoscopic finding of MCL, although isolated polyps or masses can also be found [3]. Besides lymphoma, the main differential diagnosis of MLP is intestinal pneumatosis. In younger patients, polyposis syndromes and inflammatory bowel disease should also be considered [4]. Regarding MCL treatment, the R-bendamustine regimen has the higher 5-year progression-free survival (65.5% vs. 55.8%), but the R-CVP regimen confers less immunosuppression [5].Ethical approval was not required for this study in accordance with local/national guidelines. Written informed consent was obtained from the patient, authorizing the publication of the clinical case and images, according to the Declaration of Helsinki.The authors have no conflict of interests to declare.The authors have no funding sources to declare.The data on this case report are not published anywhere because they contain information that may compromise the privacy of the patient, but they may be available if requested to Sofia Bragança.Sofia Bragança obtained the data, wrote the manuscript, and reviewed the literature. André Pereira reviewed the histopathological findings and provided the histopathological images as well as explanation. Filipa Moita provided clinical data on the diagnosis and treatment of lymphoma as well critical revision of the manuscript. Gonçalo Alexandrino, Mariana Nuno Costa, and David Horta were responsible for critical revision of the manuscript. All authors approved the published version of the manuscript.

2 May 2024 in Digestive Endoscopy
Verified
Journal Article
Open access
SBSofia Bragança
Sofia Bragança
LLLuís Carvalho Lourenço
Luís Carvalho Lourenço
MCMariana Cardoso
Mariana Cardoso

14 April 2023 in Endoscopy
Verified
Journal Article
Closed access
FCF. Pereira Correia
F. Pereira Correia
SBSofia Bragança
Sofia Bragança
FFF. Bordalo Ferreira
F. Bordalo Ferreira
MCMariana Cardoso
Mariana Cardoso
LLL. Carvalho Lourenço
L. Carvalho Lourenço
Text Gastric lipomas represent 1-3% of all gastric tumors, most of which are asymptomatic. Rarely, large gastric lipoma (>4 cm) can cause gastric outlet obstruction or bleeding due to mucosal erosion. Traditionally, the approach to symptomatic gastric lipomas is surgical. The endoscopic approach plays an increasingly important role, especially in not-fit for surgery patients and in lipomas with a greater submucosal component (instead of subserosal). We present a case of gastric lipoma managed endoscopically (ESD) with great efficacy and safety [1] [2] [3]. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany